Compare · ASTH vs G
ASTH vs G
Side-by-side comparison of Astrana Health Inc. (ASTH) and Genpact Limited (G): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ASTH and G operate in Professional Services (Consumer Discretionary), so they compete in similar markets.
- G is the larger of the two at $6.29B, about 3.3x ASTH ($1.89B).
- Over the past year, ASTH is up 11.5% and G is down 6.5% - ASTH leads by 18.0 points.
- Both names hit the wire about 6 times in the past 4 weeks.
- G has more recent analyst coverage (14 ratings vs 8 for ASTH).
- Company
- Astrana Health Inc.
- Genpact Limited
- Price
- $36.77-3.43%
- $37.25-0.92%
- Market cap
- $1.89B
- $6.29B
- 1M return
- +7.23%
- +6.58%
- 1Y return
- +11.46%
- -6.54%
- Industry
- Professional Services
- Professional Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2007
- News (4w)
- 6
- 6
- Recent ratings
- 8
- 14
Genpact Limited
Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. It operates in three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services. The company's finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; financial planning and analysis consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls. It also provides supply chain design, planning, inventory optimization, transportation and logistics management, and after-sales services; sourcing and procurement services comprising direct and indirect strategic sourcing, category management, spend analytics, procurement operation, master data management, and other procurement and supply chain advisory services; and sales and commercial services in the lead-to-quote, quote-to-order, and customer service areas. In addition, the company offers IT services, which include end-user computing support, infrastructure management, application production support, and database management services; and transformation services that include digital solutions, consulting services, and analytics services and solutions. It serves banking, capital market, insurance, consumer goods, retail, life science, healthcare, high tech, and manufacturing and service industries. Genpact Limited was founded in 1997 and is based in Hamilton, Bermuda.
Latest ASTH
- SEC Form 4 filed by Astrana Health Inc.
- Verda Healthcare, Inc. and AstranaCare Partners Form a Multi-State Partnership
- Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call
- SEC Form 4 filed by Astrana Health Inc.
- SEC Form 4 filed by Astrana Health Inc.
- SEC Form 4 filed by Astrana Health Inc.
- Astrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 8-K filed by Astrana Health Inc.
- SVP - Accounting (PAO) Vong John covered exercise/tax liability with 96 shares, decreasing direct ownership by 0.43% to 22,330 units (SEC Form 4) to satisfy withholding tax
- Oppenheimer initiated coverage on Astrana Health with a new price target
Latest G
- Genpact Limited Board Declares Quarterly Cash Dividend
- Genpact Launches Agentic Accounts Receivable Suite to Optimize Cash Flow and Working Capital
- Genpact to Report Third Quarter 2026 Results
- SEC Form EFFECT filed by Genpact Limited
- SEC Form 424B3 filed by Genpact Limited
- Amendment: SEC Form S-4/A filed by Genpact Limited
- Amendment: Genpact Limited filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Amendment: SEC Form S-4/A filed by Genpact Limited
- President and CEO Kalra Balkrishan sold $367,900 worth of shares (10,000 units at $36.79), decreasing direct ownership by 2% to 501,114 units (SEC Form 4)
- Genpact Wins in the Inaugural 2026 HFS Services-as-Software Awards